Никлозамид (Niclosamide)
Международное непатентованное наименование
Никлозамид (Niclosamide)
Торговое наименование
Niclocide, Fenasal, Phenasal
Производитель, страна
-
Лекарственная форма
-
Механизм действия
Niclosamide is a bioavailable chlorinated salicylanilide, with potential antiviral and known anthelmintic activity. Antihelminth activity is achieved by inhibiting glucose uptake, oxidative phosphorylation, and anaerobic metabolism in the tapeworm. Anticoronaviral activity is not well understood, but it is possible that niclosamide inhibits S-phase kinase-associated protein 2 (SKP2). SKP2 is known to tag Benclin 1 (BECN1) for degradation and SKP2 inhibition increases the BENC1 level, enhances autophagy, and efficiently reduces coronavirus replication.
Публикации COVID-19
Dose prediction for repurposing nitazoxanide in SARS-CoV-2 treatment or chemoprophylaxis. DOI: 10.1101/2020.05.01.20087130.
, , et al.
Med Hypotheses. 2020 Apr 22;140:109765. DOI: 10.1016/j.mehy.2020.109765.
Клинические исследования
1.
Название протокола
Efficacy of HYdroxychloroquine and DILtiazem-nIClosamide Combination for the Treatment of Non-severe Forms of SARS-CoV2 Infection in Patients With Co-morbidities: Multicenter, Randomized, Open-labeled Controlled Trial
Дата начала и окончания КИ
May 2020 - May 2023
Название организации, проводящей КИ
University Hospital, Lille
Страны
France
Фаза
III
Кол-во пациентов
480
2.
Название протокола
The Results of COVID 19 Treatment: A Real-life Experience on Patients With COVID 19
Дата начала и окончания КИ
April 30, 2020 - December 2029
Название организации, проводящей КИ
Tanta University
Страны
Egypt
Фаза
II-III
Кол-во пациентов
120